Advanced Enzyme Technologies Limited (ADVENZYMES) Financial History

Name: Advanced Enzyme Technologies Limited (ADVENZYMES) financial statement history
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Basic Materials · Specialty Chemicals · DATA UPDATED 2026-09-20

Advanced Enzyme Technologies Limited (ADVENZYMES) operates in the Specialty Chemicals industry and is headquartered in Thane, India with about 409 employees. Its market capitalization is roughly ₹32 billion. In the fiscal year ended 2026-03-31, ADVENZYMES reported ₹7.4B in revenue and ₹1.7B in net income.

Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally.

Interactive charts & full statements →

ADVENZYMES Revenue & Earnings History — Annual Income Statement

Income statement	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Revenue	₹7.4B	₹6.4B	₹6.2B	₹5.4B
Gross Profit	₹5.4B	₹4.7B	₹4.6B	₹4.0B
Operating Income (EBIT)	₹1.9B	₹1.6B	₹1.7B	₹1.4B
Net Income	₹1.7B	₹1.3B	₹1.3B	₹1.1B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ADVENZYMES Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Total Revenue	₹1.9B	₹2.0B	₹1.7B	₹1.8B	₹1.9B
Gross Profit	₹1.4B	₹1.5B	₹1.3B	₹1.4B	₹1.4B
Operating Income (EBIT)	₹411M	₹530M	₹391M	₹500M	₹468M
Net Income	₹371M	₹430M	₹425M	₹433M	₹399M

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ADVENZYMES Free Cash Flow History

Cash flow	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Dividends Paid	(₹598M)	(₹590M)	(₹567M)	(₹125M)	—

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

ADVENZYMES Balance Sheet History

Balance sheet	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Total Assets	₹18.4B	₹16.2B	₹15.4B	₹14.2B
Total Liabilities	₹1.6B	₹1.5B	₹1.6B	₹1.4B

INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ADVENZYMES viewer.

Other Companies in Specialty Chemicals

4112 · Hodogaya Chemical Co., Ltd. — JPY 34 billion
4064 · Nippon Carbide Industries Co., Inc. — JPY 33 billion
STA · Sri Trang Agro-Industry Public Company Limited — THB 33 billion
NOCIL · NOCIL Limited — ₹32 billion
APCOTEXIND · Apcotex Industries Limited — ₹31 billion
JUBLCPL · Jubilant Agri and Consumer Products Limited — ₹30 billion
TOA · TOA Paint (Thailand) Public Company Limited — THB 30 billion
GIVN · Givaudan SA — CHF 30 billion

← ADVENTHTL All “A” companies ADVICE →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.